PURPOSE: Although activated protein C (APC) is effective in preventing the death of retinal neurons in ischemic retinopathy, it is not known at what concentrations it becomes retinotoxic. The purpose of this study was to determine the concentrations of intravitreal APC that are safe and those that are toxic for the retina, using rabbit eyes. METHODS: The left eyes of 12 rabbits received an intravitreal injection of 1.5 to 150 μg of APC in 0.1 ml of saline. The fellow eyes were treated with an intravitreal injection of the same amount of saline. Slit-lamp examination, fundus examination, fluorescein angiography (FA), and electroretinograms (ERGs) were performed before and at different times after the injection. The eyes were enucleated at 6 months after the injection and examined histologically. RESULTS: The clinical and histological differences between the control eyes and the eyes that had APC injections up to 15 μg were not significant. Localized retinal edema was observed in two of three eyes with 150 μg of APC immediately after the injection. In these two eyes, chorioretinal atrophy was observed in the area of the retinal edema at 6 months, which corresponded with a hyperfluorescent area in the FA images and focal retinal degeneration histologically. No significant changes were detected in the full-field ERGs in the eyes treated even with 150 μg of APC throughout the observation period. CONCLUSION: Our results show that an intravitreal injection of APC at a dose ≤15 μg is safe, but 150 μg of APC can be toxic to the retina.
PURPOSE: Although activated protein C (APC) is effective in preventing the death of retinal neurons in ischemic retinopathy, it is not known at what concentrations it becomes retinotoxic. The purpose of this study was to determine the concentrations of intravitreal APC that are safe and those that are toxic for the retina, using rabbit eyes. METHODS: The left eyes of 12 rabbits received an intravitreal injection of 1.5 to 150 μg of APC in 0.1 ml of saline. The fellow eyes were treated with an intravitreal injection of the same amount of saline. Slit-lamp examination, fundus examination, fluorescein angiography (FA), and electroretinograms (ERGs) were performed before and at different times after the injection. The eyes were enucleated at 6 months after the injection and examined histologically. RESULTS: The clinical and histological differences between the control eyes and the eyes that had APC injections up to 15 μg were not significant. Localized retinal edema was observed in two of three eyes with 150 μg of APC immediately after the injection. In these two eyes, chorioretinal atrophy was observed in the area of the retinal edema at 6 months, which corresponded with a hyperfluorescent area in the FA images and focal retinal degeneration histologically. No significant changes were detected in the full-field ERGs in the eyes treated even with 150 μg of APC throughout the observation period. CONCLUSION: Our results show that an intravitreal injection of APC at a dose ≤15 μg is safe, but 150 μg of APC can be toxic to the retina.
Authors: Berislav V Zlokovic; Chunling Zhang; Dong Liu; Jose Fernandez; John H Griffin; Michael Chopp Journal: Ann Neurol Date: 2005-09 Impact factor: 10.422
Authors: Dong Liu; Tong Cheng; Huang Guo; José A Fernández; John H Griffin; Xiaomei Song; Berislav V Zlokovic Journal: Nat Med Date: 2004-10-31 Impact factor: 53.440
Authors: Jeffrey S Heier; Andrew N Antoszyk; Peter Reed Pavan; Steven R Leff; Philip J Rosenfeld; Thomas A Ciulla; Richard F Dreyer; Ronald C Gentile; Judy P Sy; Gary Hantsbarger; Naveed Shams Journal: Ophthalmology Date: 2006-02-14 Impact factor: 12.079
Authors: Akanksha Gupta; David T Berg; Bruce Gerlitz; Mark A Richardson; Elizabeth Galbreath; Samreen Syed; Avadhesh C Sharma; Stephen F Lowry; Brian W Grinnell Journal: Shock Date: 2007-10 Impact factor: 3.454
Authors: Huang Guo; Dong Liu; Harris Gelbard; Tong Cheng; Rae Insalaco; José A Fernández; John H Griffin; Berislav V Zlokovic Journal: Neuron Date: 2004-02-19 Impact factor: 17.173